MacroGenics Inc — Quarterly Cash Flow (NASDAQ:MGNX) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 264.49 M261.65 M224.56 M245.42 M270.76 M Total liabilities 144.43 M145.6 M145.45 M198.8 M203.76 M Total equity 120.07 M116.06 M79.12 M46.62 M67 M Total liabilities & shareholders' equities 264.49 M261.65 M224.56 M245.42 M270.76 M Total debt ————— Net debt —————

Notizie

BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates

Le azioni MacroGenics scendono dopo il blocco clinico parziale della FDA

MacroGenics stock falls after FDA places partial clinical hold

Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)

Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes

FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children

Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3

MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates

Gli EPS di MacroGenics Inc hanno battuto le aspettative per 0,68$, il fatturato supera le previsioni

MacroGenics Inc earnings beat by $0.68, revenue topped estimates

MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Stryker (SYK) Q3 Earnings and Revenues Beat Estimates